Real-world effectiveness and safety of ustekinumab in bio-naive patients with moderate-to-severe Crohn's disease: A Canadian multi-center study.

Bessissow, Talat; Narula, Neeraj; Ma, Christopher; In, Tracy S H; Eberg, Maria; Karra, Kinda; Jairath, Vipul

Bessissow, Talat; Narula, Neeraj; Ma, Christopher; In, Tracy S H; Eberg, Maria; Karra, Kinda; Jairath, Vipul.

Affiliation

Bessissow T; Division of Gastroenterology, Department of Medicine, McGill University Health Center, Montreal, QC, Canada. Electronic address: talat.bessissow@mcgill.ca.
Narula N; McMaster University, Hamilton, ON, Canada.
Ma C; University of Calgary, Calgary, AB, Canada.
In TSH; Janssen Inc., Toronto, ON, Canada.
Eberg M; IQVIA Solutions Canada Inc., Kirkland, QC, Canada.
Karra K; Janssen Inc., Toronto, ON, Canada.
Jairath V; Western University, London, Ontario, Canada.

Dig Liver Dis ; 56(1): 61-69, 2024 Jan.

Article in En | MEDLINE | ID: mdl-37716860

Subject(s)
Key words

Biologic; Effectiveness; Inflammatory bowel disease; Persistence

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crohn Disease / Ustekinumab Type of study: Clinical_trials / Guideline Limits: Humans Country/Region as subject: America do norte Language: En Journal: Dig Liver Dis Journal subject: GASTROENTEROLOGIA Year: 2024 Document type: Article Country of publication: Países Bajos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google